{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:59:34Z","timestamp":1790362774617,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T00:00:00Z","timestamp":1783123200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"vor","delay-in-days":83,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U22A2090"],"award-info":[{"award-number":["U22A2090"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82470187"],"award-info":[{"award-number":["82470187"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010166","name":"Xiamen Municipal Bureau of Science and Technology","doi-asserted-by":"publisher","award":["3502Z20244015"],"award-info":[{"award-number":["3502Z20244015"]}],"id":[{"id":"10.13039\/100010166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010166","name":"Xiamen Municipal Bureau of Science and Technology","doi-asserted-by":"publisher","award":["3502Z20234001"],"award-info":[{"award-number":["3502Z20234001"]}],"id":[{"id":"10.13039\/100010166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2023J06054"],"award-info":[{"award-number":["2023J06054"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"DOI":"10.1186\/s12916-026-05045-x","type":"journal-article","created":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T07:18:32Z","timestamp":1783149512000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Therapeutic activation of PPAR\u03b1 contributes to NOTCH1 inhibition in T-cell acute lymphoblastic leukemia"],"prefix":"10.1186","volume":"24","author":[{"given":"Wenjuan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmei","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiazhen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuman","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianyu","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,4]]},"reference":[{"issue":"10230","key":"5045_CR1","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/S0140-6736(19)33018-1","volume":"395","author":"F Malard","year":"2020","unstructured":"Malard F, Mohty M. Acute lymphoblastic leukaemia. Lancet. 2020;395(10230):1146\u201362.","journal-title":"Lancet"},{"issue":"6","key":"5045_CR2","doi-asserted-by":"publisher","first-page":"e577","DOI":"10.1038\/bcj.2017.53","volume":"7","author":"T Terwilliger","year":"2017","unstructured":"Terwilliger T, Abdul-Hay M. Acute lymphoblastic leukemia: a comprehensive review and 2017 update. Blood Cancer J. 2017;7(6):e577.","journal-title":"Blood Cancer J"},{"issue":"1","key":"5045_CR3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1158\/2643-3230.BCD-20-0093","volume":"2","author":"V Cordo","year":"2021","unstructured":"Cordo V, van der Zwet JCG, Cante-Barrett K, Pieters R, Meijerink JPP. T-cell Acute Lymphoblastic Leukemia: A Roadmap to Targeted Therapies. Blood Cancer Discov. 2021;2(1):19\u201331.","journal-title":"Blood Cancer Discov"},{"issue":"14","key":"5045_CR4","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1182\/blood.2023022920","volume":"145","author":"P P\u00f6l\u00f6nen","year":"2025","unstructured":"P\u00f6l\u00f6nen P, Mullighan CG, Teachey DT. Classification and risk stratification in T-lineage acute lymphoblastic leukemia. Blood. 2025;145(14):1464\u201374.","journal-title":"Blood"},{"issue":"11","key":"5045_CR5","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.3324\/haematol.2020.247031","volume":"105","author":"H Inaba","year":"2020","unstructured":"Inaba H, Mullighan CG. Pediatric acute lymphoblastic leukemia. Haematologica. 2020;105(11):2524\u201339.","journal-title":"Haematologica"},{"issue":"1","key":"5045_CR6","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1182\/blood.2023023156","volume":"145","author":"N G\u00f6kbuget","year":"2025","unstructured":"G\u00f6kbuget N, Steffen B. How I treat older patients with Ph\/BCR-ABL-negative acute lymphoblastic leukemia. Blood. 2025;145(1):53\u201363.","journal-title":"Blood"},{"issue":"5694","key":"5045_CR7","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1126\/science.1102160","volume":"306","author":"AP Weng","year":"2004","unstructured":"Weng AP, Ferrando AA, Lee W, Morris JPt, Silverman LB, Sanchez-Irizarry C, et al. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science. 2004;306(5694):269\u201371.","journal-title":"Science"},{"issue":"8","key":"5045_CR8","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/nrc.2016.63","volume":"16","author":"L Belver","year":"2016","unstructured":"Belver L, Ferrando A. The genetics and mechanisms of T cell acute lymphoblastic leukaemia. Nat Rev Cancer. 2016;16(8):494\u2013507.","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"5045_CR9","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.pharmthera.2013.09.005","volume":"141","author":"N Takebe","year":"2014","unstructured":"Takebe N, Nguyen D, Yang SX. Targeting notch signaling pathway in cancer: clinical development advances and challenges. Pharmacol Ther. 2014;141(2):140\u20139.","journal-title":"Pharmacol Ther"},{"key":"5045_CR10","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1126\/scitranslmed.aau6246","volume":"11","author":"RA Habets","year":"2019","unstructured":"Habets RA, de Bock CE, Serneels L, Lodewijckx I, Verbeke D, Nittner D, et al. Safe targeting of T cell acute lymphoblastic leukemia by pathology-specific NOTCH inhibition. Sci Transl Med. 2019;11:494.","journal-title":"Sci Transl Med"},{"issue":"4","key":"5045_CR11","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/ni.3691","volume":"18","author":"AV Villarino","year":"2017","unstructured":"Villarino AV, Kanno Y, O\u2019Shea JJ. Mechanisms and consequences of Jak-STAT signaling in the immune system. Nat Immunol. 2017;18(4):374\u201384.","journal-title":"Nat Immunol"},{"issue":"8","key":"5045_CR12","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1038\/s41375-018-0117-x","volume":"32","author":"B Wingelhofer","year":"2018","unstructured":"Wingelhofer B, Neubauer HA, Valent P, Han X, Constantinescu SN, Gunning PT, et al. Implications of STAT3 and STAT5 signaling on gene regulation and chromatin remodeling in hematopoietic cancer. Leukemia. 2018;32(8):1713\u201326.","journal-title":"Leukemia"},{"issue":"5","key":"5045_CR13","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1158\/2159-8290.CD-12-0504","volume":"3","author":"T Sanda","year":"2013","unstructured":"Sanda T, Tyner JW, Gutierrez A, Ngo VN, Glover J, Chang BH, et al. TYK2-STAT1-BCL2 pathway dependence in T-cell acute lymphoblastic leukemia. Cancer Discov. 2013;3(5):564\u201377.","journal-title":"Cancer Discov"},{"issue":"12","key":"5045_CR14","doi-asserted-by":"publisher","first-page":"10306","DOI":"10.3390\/ijms241210306","volume":"24","author":"JS Kim","year":"2023","unstructured":"Kim JS, Shin MJ, Lee SY, Kim DK, Choi KU, Suh DS, et al. CD109 Promotes Drug Resistance in A2780 Ovarian Cancer Cells by Regulating the STAT3-NOTCH1 Signaling Axis. Int J Mol Sci. 2023;24(12):10306.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"5045_CR15","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1172\/JCI27989","volume":"116","author":"P Lefebvre","year":"2006","unstructured":"Lefebvre P, Chinetti G, Fruchart JC, Staels B. Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis. J Clin Invest. 2006;116(3):571\u201380.","journal-title":"J Clin Invest"},{"issue":"10","key":"5045_CR16","doi-asserted-by":"publisher","first-page":"3028","DOI":"10.1158\/1078-0432.CCR-05-2556","volume":"12","author":"M Grabacka","year":"2006","unstructured":"Grabacka M, Plonka PM, Urbanska K, Reiss K. Peroxisome proliferator-activated receptor alpha activation decreases metastatic potential of melanoma cells in vitro via down-regulation of Akt. Clin Cancer Res. 2006;12(10):3028\u201336.","journal-title":"Clin Cancer Res"},{"key":"5045_CR17","doi-asserted-by":"publisher","first-page":"215997","DOI":"10.1016\/j.canlet.2022.215997","volume":"554","author":"H Zhou","year":"2023","unstructured":"Zhou H, Jiang Y, Huang Y, Zhong M, Qin D, Xie C, et al. Therapeutic inhibition of PPAR\u03b1-HIF1\u03b1-PGK1 signaling targets leukemia stem and progenitor cells in acute myeloid leukemia. Cancer Lett. 2023;554:215997.","journal-title":"Cancer Lett"},{"issue":"8","key":"5045_CR18","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/s41419-023-06075-6","volume":"14","author":"C Xie","year":"2023","unstructured":"Xie C, Zhou H, Qin D, Zheng H, Tang Y, Li W, et al. Bcl-2 inhibition combined with PPAR\u03b1 activation synergistically targets leukemic stem cell-like cells in acute myeloid leukemia. Cell Death Dis. 2023;14(8):573.","journal-title":"Cell Death Dis"},{"issue":"23","key":"5045_CR19","doi-asserted-by":"publisher","first-page":"5430","DOI":"10.1158\/1078-0432.CCR-24-0796","volume":"30","author":"H Zhou","year":"2024","unstructured":"Zhou H, Qin D, Xie C, Zhou J, Jia S, Zhou Z, et al. Combinations of HDAC Inhibitor and PPAR Agonist Induce Ferroptosis of Leukemic Stem Cell-like Cells in Acute Myeloid Leukemia. Clin Cancer Res. 2024;30(23):5430\u201344.","journal-title":"Clin Cancer Res"},{"issue":"9","key":"5045_CR20","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1158\/2159-8290.CD-14-0353","volume":"4","author":"TN Chonghaile","year":"2014","unstructured":"Chonghaile TN, Roderick JE, Glenfield C, Ryan J, Sallan SE, Silverman LB, et al. Maturation stage of T-cell acute lymphoblastic leukemia determines BCL-2 versus BCL-XL dependence and sensitivity to ABT-199. Cancer Discov. 2014;4(9):1074\u201387.","journal-title":"Cancer Discov"},{"issue":"1","key":"5045_CR21","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/s41375-018-0201-2","volume":"33","author":"Z Li","year":"2019","unstructured":"Li Z, He S, Look AT. The MCL1-specific inhibitor S63845 acts synergistically with venetoclax\/ABT-199 to induce apoptosis in T-cell acute lymphoblastic leukemia cells. Leukemia. 2019;33(1):262\u20136.","journal-title":"Leukemia"},{"issue":"1","key":"5045_CR22","doi-asserted-by":"publisher","first-page":"e1593","DOI":"10.1038\/cddis.2014.525","volume":"6","author":"GS Choudhary","year":"2015","unstructured":"Choudhary GS, Al-Harbi S, Mazumder S, Hill BT, Smith MR, Bodo J, et al. MCL-1 and BCL-xL-dependent resistance to the BCL-2 inhibitor ABT-199 can be overcome by preventing PI3K\/AKT\/mTOR activation in lymphoid malignancies. Cell Death Dis. 2015;6(1):e1593.","journal-title":"Cell Death Dis"},{"issue":"15","key":"5045_CR23","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1016\/j.scib.2021.03.019","volume":"66","author":"L Ji","year":"2021","unstructured":"Ji L, Song W, Fang H, Li W, Geng J, Wang Y, et al. Efficacy and safety of chiglitazar, a novel peroxisome proliferator-activated receptor pan-agonist, in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, phase 3 trial (CMAP). Sci Bull (Beijing). 2021;66(15):1571\u201380.","journal-title":"Sci Bull (Beijing)"},{"issue":"6","key":"5045_CR24","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1038\/leu.2011.358","volume":"26","author":"J Nordlund","year":"2012","unstructured":"Nordlund J, Kiialainen A, Karlberg O, Berglund EC, G\u00f6ransson-Kultima H, S\u00f8nderk\u00e6r M, et al. Digital gene expression profiling of primary acute lymphoblastic leukemia cells. Leukemia. 2012;26(6):1218\u201327. https:\/\/identifiers.org\/geo:GSE26530.","journal-title":"Leukemia"},{"issue":"12","key":"5045_CR25","doi-asserted-by":"publisher","first-page":"116623","DOI":"10.1016\/j.celrep.2025.116623","volume":"44","author":"B Xu","year":"2025","unstructured":"Xu B, Hou X, Wang M, Qiu L, Chen X, Deng G, et al. Fatty acids modulate the colorectal cancer immune microenvironment via regulating the interaction and transactivation of PPAR\u03b1\/\u03b4 and P53. Cell Rep. 2025;44(12):116623.","journal-title":"Cell Rep"},{"issue":"6","key":"5045_CR26","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.bcp.2005.12.017","volume":"71","author":"L Valentino","year":"2006","unstructured":"Valentino L, Pierre J. JAK\/STAT signal transduction: regulators and implication in hematological malignancies. Biochem Pharmacol. 2006;71(6):713\u201321.","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"5045_CR27","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.pharmthera.2009.12.001","volume":"125","author":"KD Wagner","year":"2010","unstructured":"Wagner KD, Wagner N. Peroxisome proliferator-activated receptor beta\/delta (PPARbeta\/delta) acts as regulator of metabolism linked to multiple cellular functions. Pharmacol Ther. 2010;125(3):423\u201335.","journal-title":"Pharmacol Ther"},{"issue":"21","key":"5045_CR28","doi-asserted-by":"publisher","first-page":"8022","DOI":"10.1128\/MCB.01091-06","volume":"26","author":"VM Sharma","year":"2006","unstructured":"Sharma VM, Calvo JA, Draheim KM, Cunningham LA, Hermance N, Beverly L, et al. Notch1 contributes to mouse T-cell leukemia by directly inducing the expression of c-myc. Mol Cell Biol. 2006;26(21):8022\u201331.","journal-title":"Mol Cell Biol"},{"issue":"9","key":"5045_CR29","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1182\/blood-2016-09-692582","volume":"129","author":"M Sanchez-Martin","year":"2017","unstructured":"Sanchez-Martin M, Ferrando A. The NOTCH1-MYC highway toward T-cell acute lymphoblastic leukemia. Blood. 2017;129(9):1124\u201333.","journal-title":"Blood"},{"issue":"1","key":"5045_CR30","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.1038\/s41467-022-30396-3","volume":"13","author":"N Baran","year":"2022","unstructured":"Baran N, Lodi A, Dhungana Y, Herbrich S, Collins M, Sweeney S, et al. Inhibition of mitochondrial complex I reverses NOTCH1-driven metabolic reprogramming in T-cell acute lymphoblastic leukemia. Nat Commun. 2022;13(1):2801.","journal-title":"Nat Commun"},{"issue":"6059","key":"5045_CR31","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1126\/science.1206727","volume":"334","author":"T Ni Chonghaile","year":"2011","unstructured":"Ni Chonghaile T, Sarosiek KA, Vo TT, Ryan JA, Tammareddi A, Moore Vdel G, et al. Pretreatment mitochondrial priming correlates with clinical response to cytotoxic chemotherapy. Science. 2011;334(6059):1129\u201333.","journal-title":"Science"},{"issue":"9","key":"5045_CR32","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1182\/blood-2016-10-706465","volume":"129","author":"T Girardi","year":"2017","unstructured":"Girardi T, Vicente C, Cools J, De Keersmaecker K. The genetics and molecular biology of T-ALL. Blood. 2017;129(9):1113\u201323.","journal-title":"Blood"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-026-05045-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-026-05045-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-026-05045-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:01:55Z","timestamp":1790359315000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12916-026-05045-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,4]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5045"],"URL":"https:\/\/doi.org\/10.1186\/s12916-026-05045-x","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,4]]},"assertion":[{"value":"6 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experiments have been supervised and approved by the Laboratory Animal Ethics and Management Committee of Xiamen University (XMULAC20220270).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have reviewed and approved the final version of the manuscript and consent to its submission to BMC Medicine.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"518"}}